AIS adenocarcinoma in situ AORRP adult onset respiratoire recurrente papillomatose BMHK baarmoederhalskanker CGIN ce
rvicale glandulaire intra-epitheliale neoplasie CIN cervicale intra-epitheliale
neoplasie CIN1 cervicale intra-epitheliale
neoplasie graad 1 CIN2 cervicale intra-epitheliale
neoplasie graad 2 CIN3 cervicale intra-epitheliale
neoplasie graad 3 CIN1+ cervicale intra-epitheliale
neoplasie vanaf graad 1 CIN2+ cervicale intra-epitheliale
neoplasie vanaf graad 2 CIN3+ cervicale intra-epitheliale
neoplasie ...[+++] vanaf graad 3 CIS carcinoma in situ EMEA European Medicines Agency FDA Food and Drugs Agency HR-HPV hoog-risico humaan papillomavirus HSIL hoge graad squameuze intra-epitheliale neoplasie IARC International Agency for Research in Cancer JORRP juvenile onset respiratoire recurrente papillomatose LR-HPV laag-risico humaan papillomavirus LSIL lage graad squameuze intra-epitheliale neoplasie PCR polymerase chain reaction RRP respiratoire recurrente papillomatose VaIN vaginale intra-epitheliale neoplasie VIN vulvaire intra-epitheliale neoplasie VLP virus-like particle